The observed improvements in respiratory efficiency and neuroprotection in MPP+-treated SH-SY5Y cells suggest that VEGF enhances mitochondrial quality rather than quantity, a mechanism that may be particularly relevant for addressing mitochondrial dysfunction in PD and other neurodegenerative conditions. This evidence concerns the gene VEGFA and Parkinson disease.